Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 03-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,045 | 3,849 | 2,894 | 8,896 | 7,613 |
| Marketable Securities | 1,500 | 3,826 | 6,259 | 8,404 | 3,593 |
| Receivables | 2,390 | 1,031 | 1,374 | 636 | 1,717 |
| Inventories | 1,498 | 2,127 | 1,388 | 1,303 | 1,461 |
| Other current assets | 1,530 | 444 | 227 | 164 | 225 |
| TOTAL | $7,964 | $11,276 | $12,142 | $19,402 | $14,609 |
| Non-Current Assets | |||||
| PPE Net | 4,559 | 5,431 | 4,760 | 2,898 | 2,315 |
| Investments And Advances | 0 | 0 | 3,087 | 5,077 | 15,752 |
| Intangibles | 94 | 94 | 94 | 0 | 0 |
| Other Non-Current Assets | 1,329 | 1,568 | 2,386 | 857 | 794 |
| TOTAL | $5,983 | $7,094 | $10,326 | $8,832 | $18,860 |
| Total Assets | $13,946 | $18,370 | $22,468 | $28,234 | $33,469 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,083 | 1,000 | 175 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,257 | 1,279 | 1,114 | 470 | 615 |
| Accrued Expenses | 404 | 461 | 433 | 439 | 354 |
| TOTAL | $5,818 | $3,245 | $2,621 | $1,089 | $1,196 |
| Non-Current Liabilities | |||||
| Long Term Debt | 917 | 2,000 | 1,325 | N/A | N/A |
| Deferred Revenues | 1,908 | 121 | 434 | 67 | 84 |
| Other Non-Current Liabilities | 350 | 371 | 0 | 0 | 0 |
| TOTAL | $1,585 | $2,790 | $1,892 | $278 | $308 |
| Total Liabilities | $7,403 | $6,035 | $4,512 | $1,367 | $1,503 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,158 | 13,742 | 13,530 | N/A | N/A |
| Common Shares | 110,705 | 109,908 | 88,777 | 88,356 | 87,990 |
| Retained earnings | -106,040 | -99,451 | -90,370 | -81,038 | -75,573 |
| Other shareholders' equity | 1,879 | 1,879 | 19,549 | 19,549 | 19,549 |
| TOTAL | $6,543 | $12,335 | $17,956 | $26,867 | $31,966 |
| Total Liabilities And Equity | $13,947 | $18,370 | $22,468 | $28,234 | $33,469 |